Ethic Inc’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,545
| Closed | -$272K | – | 1273 |
|
|
2025
Q1 | $272K | Sell |
2,545
-1,647
| -39% | -$176K | 0.01% | 975 |
|
|
2024
Q4 | $572K | Buy |
4,192
+1,073
| +34% | +$146K | 0.01% | 757 |
|
|
2024
Q3 | $430K | Buy |
3,119
+207
| +7% | +$28.5K | 0.01% | 797 |
|
|
2024
Q2 | $401K | Sell |
2,912
-207
| -7% | -$28.5K | 0.01% | 814 |
|
|
2024
Q1 | $430K | Sell |
3,119
-1,337
| -30% | -$184K | 0.01% | 796 |
|
|
2023
Q4 | $587K | Buy |
4,456
+811
| +22% | +$107K | 0.02% | 688 |
|
|
2023
Q3 | $410K | Buy |
+3,645
| New | +$410K | 0.01% | 737 |
|